Skip to content

Hendrik Peter Scholl, Chief Medical Officer at Belite Bio, sold BLTE on Oct 1, 2026

Data as of Oct 16

▼ SELL$13.1K78 shares at $167.59Hendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc
Watch BLTE
Traded
Oct 1, 2026
Disclosed
Oct 5, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Hendrik Peter Scholl, Chief Medical Officer at Belite Bio, sold BLTE on Oct 1, 2026TRADEDDISCLOSED
BLTESimilar stocks (XLV — its sector index fund), rebased to BLTE's price on the disclosure day
BLTE since disclosure
−10.3%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund

Change in closing price from Oct 5, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$2Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$8.3Kdisclosed Oct 5 · filed 4 days after the trade
  3. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$4Kdisclosed Oct 5 · filed 4 days after the trade
  4. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$19.9Kdisclosed Oct 5 · filed 4 days after the trade
  5. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$2.4Kdisclosed Oct 5 · filed 4 days after the trade
  6. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$340disclosed Oct 5 · filed 4 days after the trade
  7. ▼ SELLHendrik Peter Scholl Chief Medical OfficerBLTE Belite Bio, Inc$32.7Kdisclosed Oct 5 · filed 4 days after the trade

See every trade on BLTE →